Anbio Biotechnology (NNNN) Other Non-Current Assets (2023)

Anbio Biotechnology's (NNNN) quarterly Other Non-Current Assets came in at $1293.0 in Q4 2023.

Anbio Biotechnology (NNNN) Other Non-Current Assets (2023) Analysis & Trends

Anbio Biotechnology (NNNN) has 1 years of Other Non-Current Assets data on file, last reported at $1293.0 in Q4 2023.

On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $1293.0 in Q4 2023; TTM through Dec 2023 was $1293.0, a N/A change from a year earlier, with the FY2023 full-year figure at $1293.0, changed N/A from the prior year.
Other Non-Current Assets for Q4 2023 stood at $1293.0.
Over the last five years, Other Non-Current Assets for NNNN reached as high as $1293.0 in Q4 2023 and fell as low as $1293.0 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	376.00 Mn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	23.08 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	210.73 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	82.80 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	672.80 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	848.00 Mn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	39.83 Mn
10	Anbio Biotechnology	425.37 Mn	413.46 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	1,293.00